Search research articles
Contact Us
Filters
Showing results (11-20 of 109) with videos related to
Page
of 11
Sort By:
Kidney International
|
August 17, 2012
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient
Jai Radhakrishnan, Daniel C Cattran
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 1, 2002
Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care
Andrew A House, Daniel C Cattran
Kidney International
|
November 14, 2016
Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation
Fernando G Cosio, Daniel C Cattran
The New England Journal of Medicine
|
October 24, 2019
Rituximab or Cyclosporine for Membranous Nephropathy. Reply
Fernando C Fervenza, Daniel C Cattran
Kidney International
|
January 10, 2017
Membranous nephropathy: integrating basic science into improved clinical management
Daniel C Cattran, Paul E Brenchley
Kidney International
|
June 18, 2016
Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
Christina M Wyatt, Daniel C Cattran
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 22, 2011
Maintenance immunosuppression in antineutrophil cytoplasmic antibody-associated vasculitis
Daniel C Cattran, Michelle A Hladunewich
Minerva Medica
|
May 31, 2019
Recent advances in risk prediction, therapeutics and pathogenesis of IgA nephropathy
Sarah M Moran, Daniel C Cattran
Kidney International Reports
|
December 18, 2023
Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy
Daniel C Cattran, Jürgen Floege, Rosanna Coppo
Clinical Journal of the American Society of Nephrology : CJASN
|
August 8, 2009
The natural history of the non-nephrotic membranous nephropathy patient
Michelle A Hladunewich, Stephan Troyanov, Jennifer Calafati, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 109) with videos related to
Sort By:
Page
of 11
Kidney International
|
August 17, 2012
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient
Jai Radhakrishnan, Daniel C Cattran
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 1, 2002
Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care
Andrew A House, Daniel C Cattran
Kidney International
|
November 14, 2016
Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation
Fernando G Cosio, Daniel C Cattran
The New England Journal of Medicine
|
October 24, 2019
Rituximab or Cyclosporine for Membranous Nephropathy. Reply
Fernando C Fervenza, Daniel C Cattran
Kidney International
|
January 10, 2017
Membranous nephropathy: integrating basic science into improved clinical management
Daniel C Cattran, Paul E Brenchley
Kidney International
|
June 18, 2016
Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
Christina M Wyatt, Daniel C Cattran
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 22, 2011
Maintenance immunosuppression in antineutrophil cytoplasmic antibody-associated vasculitis
Daniel C Cattran, Michelle A Hladunewich
Minerva Medica
|
May 31, 2019
Recent advances in risk prediction, therapeutics and pathogenesis of IgA nephropathy
Sarah M Moran, Daniel C Cattran
Kidney International Reports
|
December 18, 2023
Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy
Daniel C Cattran, Jürgen Floege, Rosanna Coppo
Clinical Journal of the American Society of Nephrology : CJASN
|
August 8, 2009
The natural history of the non-nephrotic membranous nephropathy patient
Michelle A Hladunewich, Stephan Troyanov, Jennifer Calafati, et al.
Page
of 11